Sprout Pharmaceuticals, Inc
Quick facts
Phase 3 pipeline
- flibanserin flexible dose · Sexual Health / Women's Health
Flibanserin is a serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist that modulates neurotransmitter activity in the brain to increase sexual desire.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: